Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.
Gurley SN, Abidi AH, Allison P, Guan P, Duntsch C, Robertson JH, Kosanke SD, Keir ST, Bigner DD, Elberger AJ, Moore BM 2nd.
Gurley SN, et al. Among authors: kosanke sd.
J Neurooncol. 2012 Nov;110(2):163-77. doi: 10.1007/s11060-012-0958-5. Epub 2012 Aug 9.
J Neurooncol. 2012.
PMID: 22875710